Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial
| Autor: | Cohen, Hannah, Hunt, Beverley J, Efthymiou, Maria, Arachchillage, Deepa R J, Mackie, Ian J, Clawson, Simon, Sylvestre, Yvonne, Machin, Samuel J, Bertolaccini, Maria L, Ruiz-Castellano, Maria, Muirhead, Nicola, Doré, Caroline J, Khamashta, Munther, Isenberg, David A |
|---|---|
| Zdroj: | In The Lancet Haematology September 2016 3(9):e426-e436 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|